In an elegant experiment by researchers at MD Anderson Cancer Center, the effects of adenoviral-mediated p53 transgene expression on the radiation response of two human prostate cancer cell lines, LNCaP and PC3 lines, was examined. This evidence concerns the gene TP53 and prostate cancer.